Shareholders meeting

Date: October 16, 2026 To To The Manager, The Manager, Listing Department, The Department of Corporate Service, National Stock Exchange of India Limited, BSE Limited, (BSE) (NSE) Phiroze Jeejeebhoy Tower, Exchange Plaza, C-1, Block-G, Bandra-Kurla Dalal Street, Complex, Bandra (E), Mumbai – 400 051. Mumbai – 400 001. Scrip Code – LINCOLN Scrip Code – 531633 Dear Sir / Madam, Sub.: Submission of Minutes of the 32nd Annual General Meeting. With reference to above, please find enclosed herewith the minutes of the 32nd Annual General Meeting of the Company held at 11:00 A.M. on Wednesday, the 30th day of September, 2026 through Video Conferencing (‘VC’) / Other Audio-Visual Means (OAVM) to seek the approval of members of the Company on resolutions set out in the Notice convening the Meeting. We request you to take note of the same. Thanking you, Yours faithfully, For Lincoln Pharmaceuticals Ltd. Trusha Shah Company Secretary & Compliance Officer Encl: a/a LINCOLN PHARMACEUTICALS L TO. HEALTHCARE FOR ALL Minutes of the 32od Annual General Meeting of the members of Lincoln Pharmaceuticals Limited held at 11;00 A.M. on Wednesday, the 30'' day of September. 2026 through Video conferencing (VC) I Other Audio Visual Means COAVM). Directors who joined the meeting through VC facility: Sr. Place from where the Name of the Director Designation No. meetina attended 1. Mr. Mahendra G. Patel Mananina Director Ahmedabad 2. Mr. Hashmukh !. Patel Whole Time Director Ahmedabad 3. Mr. Munial M. Patel Whole Time Director Ahmedabad 4. Mr. Ashish R. Patel Whole Time Director Ahmedabad 5. Mr. Rainikant Patel Non-Executive Director Ahmedabad 6. Mr. Saurin Parikh Indenendent Director Ahmedabad 7. Ms. Seema Mehta Independent Director Ahmedabad Other panelists who joined the meeting through VC facility: Sr. Name of the Place from where the Designation No. nanelists meetina attended Mr. Darshit A. Shah 1. Chief Financial Officer Ahmedabad Statutory Auditors, Mr. Samir Shah partner of Samir M. Shah & 2. Ahmedabad Associates, Chartered Accountants Secretarial Auditor, Proprietor of M/s. Ankit Sethi & 3. Mr. Ankit Sethi Mumbai Associates, cornoanv Secretaries Scrutinizer, 4. Mr. Umesh G. Parikh Partner of Parikh Dave & Associates, Ahmedabad Cornoanv Secretaries Regd. Office, "Lincoln House". 8/h Satyam Complex, Science City Road, Sola. Ahmedabad-380060. Gujarat, India. Phone: +91-79-4107 8000 I CIN L24230GJl995PLC024288 E-mail: mfo@lmcolnpharma.com I Website: www.llncolnpharma.com Factory: Tnmul Estate, Khatraj, Tal - Kalol. Dist.- Gandhmagar-382721, Gu1arat State, India Phone: +91-79-4913 5000 I E-mail: khatraJlg\mcolnpharma.com NLOCNIL .DTL SLACITUECAMRAHP LLA ROF ERACHTLAEH :NAMRIAHC ot eud eht fo MGA eht ot elba ton saw eht fo namriahC ,hahS rohsiK .rM ecniS ynapmoC nioj ynapmoC sa detcele saw eht fo rotceriD ,letaP ardnehaM .rM ,snosaer lanosrep ylsuominanu ynapmoC gniganaM eht rof namriahC eht .gniteem :MUROUQ saw maerts evil eht eht fo srebmem fo rebmun taht demrifnoc tI ytilicaf elbaliava denioj ynapmoC etisiuqer eht ni sa sa dna dtL secivreS lartneC no deriuqer ,murouq yrassecen mroftalp yrotisopeD )LSDC( )aidnI( .redro ni eb ot decnuonna saw eht ,tcA fo gniteem ,tneserp seinapmoC snoisivorp 3102 gnieb snaeM lausiV-oiduA rehtO / ecnerefnoC oediV eht srebmeM 08 hguorht gniteem denioj gnidulcni dezirohtua .sevitatneserper ni ton saw fo eht MVAO / CV denevnoc saw eht ecniS dedivorp yxorp gnitnioppa ytilicaf hguorht gniteem .IBES dna ACM deussi sralucric suoirav eht htiw ecnadrocca yb :NOITCUDORTNI dna seitiruceS dna sriaffA fo deussi sralucric suoirav fo nI yb egnahcxE etaroproC yrtsiniM ecnailpmoc oediV dleh saw eht fo lareneG launnA dn23 eht ,aidnI fo draoB gnicnerefnoC hguorht ynapmoC gniteem snoituloser no eht fo srebmem fo eht kees ot snaeM lausiV oiduA rehtO / )'CV'( ynapmoC lavorppa )'MVAO'( taht decnuonna rehtruf eh dna lareneG launnA eht ecitoN eht ni tuo tes gniganaM gniteeM gninevnoc laicnaniF feihC ,srotceriD emiT elohW ,rotceriD yrotutatS ,reciffO tnednepednI ,srotceriD ,srotceriD eht dah eht fo rehto dna sreziniturcS ,rotiduA lairaterceS ,srotiduA gniteem denioj ynapmoC stsilenap oediv .gnicnerefnoc hguorht :SREBMEM EHT DT SSERDDA ROTCERID GNIGANAM hcnual eht no srebmem eht ot noitcudortni feirb dna redloherahs eht rotceriD ehT evag deteerg gniganaM eht ,tnalP eht ,tekram citsemod eht ni snoisivid wen ruof fo lanoitarepo dednapxe ,stropxe jartahK gniworg lanoitanretni dna citsemod taht meht demrofni osla eH ta !PA wen eht dna tnalP anasheM .jartahK ytilicaf dna dniw eht taht dna selas latot fo %26 dna %83 tuoba detubirtnoc stekram s'ynapmoC ,ylevitcepser sti fo %001 teem ralos .stnemeriuqer stcejorp ygrene :SRETSIGER YROTUTATS FO NOITCEPSNI rof elbaliava era stnemucod dna eht taht decnuonna saw tI yllacinortcele sretsiger yrotutats yrassecen .sserddA liaM-E rieht morf srebmem eht ot deretsiger tseuqer gnikam yb noitcepsni .aidnI .tarajuG ,060083-dabademhA .daoR ytiC ecneicS .h/B ,"esuoH nlocniL" :eciffO .aloS .xelpmoC maytaS .d 882420CLP5991JG03242L NIC I 0008 7014-97·19+ :en moc.amrahpnlocniL.www :etisbeW I :lia moc.amrahpnlocnil@ofni aidnI .etatS tarajuG ,127283-raganihdnaG ·.tsiD .iolaK -.iaT ,elatsE lumirT .jarlahK :yrot moc.amrahpnlocml@jartahk :liam-E I 0005 3194-97-19+ :en LINCOLN PHARMACEUTICALS L TO. HEALTHCARE FOR ALL NOTICE OF THE MEETING: With the consent of the Members present, the notice dated August 13, 2026 convening the 32� Annual General Meeting as circulated to the members was taken as read. AUDITORS' REPORT: There were no qualifications, observations or adverse remarks in the Independent Auditors' Reports and Secretarial Auditors' Report contain observations, answers of which have been suitably been provided in the Directors' report hence thereafter it was taken as read. QUESTION / QUERIES FROM SHAREHOLDERS: Thereafter it was informed that Six members have registered themselves as speaker. Among which one member has already sent email raising various questions/queries. Three speaker shareholders who were present in the meeting asked their queries during the session. Mr. Munjal Patel, Whole Time Director of the Company communicate and replied queries satisfactorily. It was further stated that due to time constrain, it would not possible to provide answer to all the queries and hence shareholders suggested to reply through Email and Company Secretary confirmed the same. REMOTE E-VOTING AND E-VOTING DURING THE AGM: It was informed that pursuant to the provisions of Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules 2014, the Company had provided remote e-Voting facility to the members of the Company in respect of ordinary and special business to be transacted at the Annual General Meebng. The e-Votinq commenced on September 26, 2026 (09:00 a.m.) and ended on September 29, 2026 (5:00 p.m.) It was also announced that the members who were present in the AGM through Video Conference and had not cast their votes on the resolutions through remote e-voting were eligible to vote through e-voting facility available during the AGM. Company had made arrangement on CDSL portal to provide facility of e voting during the Annual General Meeting to those members who could not cast their vote by remote e Voting. SCRUTINIZER REPORT AND RESULT OF E·VOTING: It was also informed that Mr. Umesh Parikh, Partner of Parikh Dave & Associates, Practicing Company Secretary were appointed as Scrutinizer to supervise the process of remote e-voting and e-voting during AGM in fair and transparent manner. It was informed that after receipt of Scrutinizer's Report the result of voting would be declared within 2 working days of the conclusion of this meeting and the same will be available on the website of the Company i.e. www.lincolnpharma.com and will also be intimated to the Stock Exchanges, i.e. NSE & BSE Regd. Office: "Lincoln House", B/h. Satyam Complew.. Science City Road, Sola. Ahmedabad-380060. Gujarat. Indi [Showing first 8,000 characters — download PDF for full document]